Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Aug 06,2015
Link between Mitochondrial Protein and Heart Failure Uncovered
    While all cells in the body rely on metabolic pathways that take place within the mitochondria, the cells of some organs, such as the brain and heart, have an essential demand for constant energy. Maintaining the proper mitochondrial homeostasis is critical for overall tissue health, as defective mitochondria have been linked to a number ofRead more
More
Aug 06,2015
Biomolecules Sorted with Catch-and-Release System
A microtubule-inspired microfluidic system that resembles a microscopic forest of arms can pluck biomolecules out of liquid mixtures, carry them from one chemical stream to another, and then release them. The system, which is dynamic and tunable, may be suitable for applications in clinical diagnostics, target characterization, environmental analysis, and chemical purification. Each "arm” insideRead more
More
Aug 05,2015
Cancer Drug Spending Reaches $100B Mark
Total global spending on cancer medicines reached the $100 billion mark last year, as patients and doctors embraced earlier diagnosis and more effective therapies requiring longer treatment durations, the IMS Institute for Healthcare Informatics said today in a report. The global market for oncology drugs—including those used in supportive care—increased 10.3% last year and hasRead more
More
Cancer Drug Spending Reaches $100B Mark
Aug 05,2015
Key Gene Linking Fast-Acting and Slow-Acting Immune Response Found
Australian scientists say they have shown that a specific gene determines the development and function of important cells that bridge the gap between our fast-acting innate and slower-acting adaptive, immune systems. STAT3, as it is known, helps protect against a variety of fungal and bacterial infections, and understanding its role may help in finding waysRead more
More
Aug 04,2015
Single Nuclear Protein Orchestrates Stem Cell Development
Think of an especially active, hands-on orchestra conductor who shuns the podium, roams the orchestra pit, and urges principle musicians from diverse ensembles to play together and realize the score. That's roughly what happens during stem cell development, except the conductor is a single "master” growth factor receptor, the orchestra pit is the nucleus, theRead more
More
Aug 04,2015
Scientists Use Molecular Can Opener to Target HIV
One of the main roadblocks that have stymied researchers' attempts at generating an effective HIV vaccine is somehow managing to get antibodies and other immune cells to attack the appropriate targets that are practically hermetically sealed within the virus. However, scientists at the Montreal University Health Centre (CHUM) believe they have found what amounts toRead more
More
Aug 04,2015
Cancer Xenograft Models
Cancer Xenograft Models Introduction Mouse models of cancer have consistently been used to determine the in vivo activity of new anti-cancer therapeutics prior to clinical development and testing in humans. The most common models are xenografts of human tumors and cell lines grown subcutaneously in immunodeficient mice such as athymic (nude) or severe combined immuneRead more
More
Cancer Xenograft Models
Aug 03,2015
Highly Conserved DNA Repair Proteins Have Role in Cancer Predisposition
During evolution and development of a species, the replication of the organism's genome can lead to a duplication of certain genes that evolve new functions. These so-called paralogs are found throughout the genome of humans, as well as other organisms, and are associated with a variety of cellular processes. Yet, the paralogs that are involvedRead more
More
Aug 03,2015
Bioinformatics Program Matches Cancer Patients with Treatments
Scientists at the University of Colorado Cancer Center have described a new tool that reportedly improves the ability to match drugs to disease. The Kinase Addiction Ranker (KAR) predicts what genetics are truly driving the cancer in any population of cells and chooses the best kinase inhibitor to silence these dangerous genetic causes of disease,Read more
More
Bioinformatics Program Matches Cancer Patients with Treatments
Jul 31,2015
Tumor Microenvironment Impacts Cancer Subtype Progression
Scientists at Cold Spring Harbor Laboratory (CSHL) report that two different mouse models of breast cancer progressed differently based on characteristics of the tumor microenvironment, which is the area of tissue in which the tumor is embedded.
More
Tumor Microenvironment Impacts Cancer Subtype Progression
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->